Skip to content
All Sections
Subscribe Now
72°F
Sunday, July 21st 2024
e-Edition
Home Page
Close Menu
News
News
Crime and Public Safety
Investigative Reporting
Politics
Health
Environment
Business
Best Reviews
Housing
Jobs
Local News
Local News
Long Beach
Los Angeles
Los Angeles County
Sports
Sports
High School Sports
Chargers
Rams
Lakers
Clippers
Dodgers
Angels
College Sports
UCLA Sports
USC Sports
Long Beach State sports
Kings
Ducks
Olympics
Boxing/MMA
Soccer
Horse Racing
Things To Do
Things To Do
Restaurants Food and Drink
Movies
Music + Concerts
Theater
TV and Streaming
Home + Garden
Travel
Amusement Parks
Comics
Puzzles
Events
Obituaries
Obituaries
News Obituaries
Place an Obituary
Opinion
Opinion
Editorials
Opinion Columns
Commentary
Letters to the Editor
Editorial Board
Endorsements
The Grunion
The Grunion
News
Education
Sports
Things to Do
Opinion
E-Edition
Advertising
Contact Us
SCNG Premium
The T.E.A.
Subscribe
Press-Telegram Store
Log In
Logout
Close Menu
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Account Settings
Contact Us
Log Out
Spoof a user
Get the latest news delivered daily!
Sign Up
Subscribe
Log In
Search
Press Telegram
72°F
Sunday, July 21st 2024
e-Edition
News
Local News
Sports
Things to Do
Obituaries
Opinion
The T.E.A.
Trending:
President Joe Biden drops out of the 2024 race. VP Harris gets his nod
SpaceX moving to Texas
Homeless pet food pantry opens
Fatal Signal Hill crash
LB Burger Week ð
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cybin Inc.
< Previous
1
2
3
4
5
6
Next >
Cybin Reports Fiscal Year 2024 Financial Results and Recent Business Highlights
June 26, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 19, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Appoints Dr. Atul Mahableshwarkar M.D., as Senior Vice President, Clinical Development
June 11, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024
May 29, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
May 14, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
May 06, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Participate at the 27th Annual Milken Institute Global Conference
April 25, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
April 18, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
April 16, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 10, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
March 18, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Initiates Phase 2 Proof-of-Concept Study of CYB004 in Generalized Anxiety Disorder
March 15, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
March 14, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Receives FDA Breakthrough Therapy Designation for its Novel Psychedelic Molecule CYB003 and Announces Positive Four-Month Durability Data in Major Depressive Disorder
March 13, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
March 12, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at the TD Cowen 44th Annual Health Care Conference
February 27, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Reports Third Quarter Financial Results and Recent Business Highlights
February 14, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
February 07, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
January 23, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
January 08, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Highlights Recent Topline Results and Outlines Key Upcoming Milestones Across its Clinical Development Programs
January 04, 2024
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Deuterated Psilocybin Analog Program
December 06, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Four Poster Presentations at the 2023 American College of Neuropsychopharmacology Annual Meeting Including CYB003 Phase 2 Topline Results
December 05, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Reports Positive Topline Data from Phase 2 Study of CYB003 in Major Depressive Disorder with 79% of Patients in Remission after Two 12mg Doses
November 30, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Host CYB003 Topline Depression Study Review and R&D Briefing on November 30, 2023, in New York City
November 20, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Release Phase 2 Topline Safety and Efficacy Data for CYB003 in Major Depressive Disorder and Host R&D Briefing on November 30, 2023
November 16, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Poster Presentation at Neuroscience 2023 Annual Meeting
November 15, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Reports Second Quarter Financial Results and Recent Business Highlights
November 14, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Closing of Offering of Units Led by One of the Company’s Largest Institutional Shareholders
November 14, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces up to US$64 Million Offering of Units
November 10, 2023
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Close